MET and gastric cancer: NRP-1 is shown to participate as co-receptors [10–14] in the activation of the VEGF/VEGFR2, EGF/EGFR and HGF/c-Met pathways, which play key roles in the proliferation and metastasis of gastric cancer cells [17, 18, 25].